Jeffrey W. Albers, Director, on August 07, 2026, sold 23,000 shares in Spyre Therapeutics (SYRE) for $2,404,190. Following the Form 4 filing with the SEC, Albers has control over a total of 9,360 common shares of the company, with 9,360 controlled indirectly.
SEC Filing:
Thomas Eugene Clark, Senior Vice President & Chief Financial Officer, on August 06, 2026, sold 17,500 shares in Global Industrial (GIC) for $684,962. Following the Form 4 filing with the SEC, Clark has control over a total of 72,231 common shares of the company, with 72,231 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/945114/000162828026055406/xslF345X05/wk-form4_1786398961.xml
Andrew Woods, General Counsel and Secretary, on August 07, 2026, sold 38,331 shares in Pubmatic (PUBM) for $688,402. Following the Form 4 filing with the SEC, Woods has control over a total of 39,761 Class A common shares of the company, with 39,761 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1422930/000196653026000012/xslF345X05/form4-08102026_090849.xml
Michael A Coke, Director, President, on August 07, 2026, sold 8,000 shares in Terreno Realty (TRNO) for $547,040. Following the Form 4 filing with the SEC, Coke has control over a total of 630,211 common shares of the company, with 425,381 shares held directly and 204,830 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1476150/000121305126000010/xslF345X05/wk-form4_1786398486.xml